Le Bert N - Search Results

1

Major open questions in the hepatitis B and D field - Proceedings of the inaugural International emerging hepatitis B and hepatitis D researchers workshop.

Tu T, Wettengel J, Xia Y, Testoni B, Littlejohn M, Le Bert N, Ebert G, Verrier ER, Tavis JE, Cohen C. Tu T, et al. Among authors: le bert n. Virology. 2024 Jul;595:110089. doi: 10.1016/j.virol.2024.110089. Epub 2024 Apr 16. Virology. 2024. PMID: 38640789 Free PMC article.

2

Immunotherapy for Chronic Hepatitis B Virus Infection.

Bertoletti A, Le Bert N. Bertoletti A, et al. Among authors: le bert n. Gut Liver. 2018 Sep 15;12(5):497-507. doi: 10.5009/gnl17233. Gut Liver. 2018. PMID: 29316747 Free PMC article. Review.

3

SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity.

Lim JME, Tan AT, Le Bert N, Hang SK, Low JGH, Bertoletti A. Lim JME, et al. Among authors: le bert n. J Exp Med. 2022 Oct 3;219(10):e20220780. doi: 10.1084/jem.20220780. Epub 2022 Aug 16. J Exp Med. 2022. PMID: 35972472 Free PMC article.

4

Quest for immunological biomarkers in the management of CHB patients.

Bertoletti A, Le Bert N. Bertoletti A, et al. Among authors: le bert n. Gut. 2023 Nov;72(11):2012-2014. doi: 10.1136/gutjnl-2023-329437. Epub 2023 Mar 15. Gut. 2023. PMID: 36922017 No abstract available.

5

Silent battles: immune responses in asymptomatic SARS-CoV-2 infection.

Le Bert N, Samandari T. Le Bert N, et al. Cell Mol Immunol. 2024 Feb;21(2):159-170. doi: 10.1038/s41423-024-01127-z. Epub 2024 Jan 15. Cell Mol Immunol. 2024. PMID: 38221577 Review.

6

Difference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions. Reply.

Tan AT, Le Bert N, Bertoletti A. Tan AT, et al. Among authors: le bert n. J Clin Invest. 2021 Dec 15;131(24):e155701. doi: 10.1172/JCI155701. J Clin Invest. 2021. PMID: 34907917 Free PMC article. No abstract available.

7

Act Early and at the Right Location: SARS-CoV-2 T Cell Kinetics and Tissue Localization.

Bertoletti A, Le Bert N, Tan AT. Bertoletti A, et al. Among authors: le bert n. Int J Mol Sci. 2022 Sep 14;23(18):10679. doi: 10.3390/ijms231810679. Int J Mol Sci. 2022. PMID: 36142588 Free PMC article. Review.

8

Fine-Tuning TLR-7-Based Therapy for Functional HBV Cure.

Bertoletti A, Le Bert N. Bertoletti A, et al. Among authors: le bert n. Hepatol Commun. 2019 Oct 1;3(10):1289-1292. doi: 10.1002/hep4.1420. eCollection 2019 Oct. Hepatol Commun. 2019. PMID: 31592063 Free PMC article.

9

Favorable vaccine-induced SARS-CoV-2-specific T cell response profile in patients undergoing immune-modifying therapies.

Qui M, Le Bert N, Chan WPW, Tan M, Hang SK, Hariharaputran S, Sim JXY, Low JGH, Ng W, Wan WY, Ang TL, Bertoletti A, Salazar E. Qui M, et al. Among authors: le bert n. J Clin Invest. 2022 Jun 15;132(12):e159500. doi: 10.1172/JCI159500. J Clin Invest. 2022. PMID: 35536644 Free PMC article.

10

SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic.

Bertoletti A, Le Bert N, Tan AT. Bertoletti A, et al. Among authors: le bert n. Immunity. 2022 Oct 11;55(10):1764-1778. doi: 10.1016/j.immuni.2022.08.008. Epub 2022 Aug 18. Immunity. 2022. PMID: 36049482 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters